Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Isaac “Zak” Kohane is the chair of biomedical informatics at Harvard Medical School. He’s uniquely situated for the explosion ...

As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

To get FDA approval, scientists must be able to demonstrate ... a professor in the Department of Environmental Health and Engineering at Johns Hopkins Bloomberg School of Public Health.

A new oral antibiotic, gepotidacin, may treat gonorrhea. The gepotidacin FDA approval may help this drug reach those who need ...

The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...

The widespread job cuts and regulatory shifts at key US health agencies ... fuelling concerns over potential delays in drug and medical device approvals. These cuts have been led by anti-vaccine ...